Meanwhile, ALDH6A1 was identified as a potential molecular signature for hepatocellular carcinoma (28), prostate cancer (29), and muscle insulin resistance in type 2 diabetes mellitus (30). Here, ALDH6A1 is linked to Insulin resistance.